المؤلفون: Barbosa AD; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Leitão AC; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., de Oliveira LC; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Rodrigues DS; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., de Farias Cabral VP; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Moreira LEA; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Silveira MJCB; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barbosa SA; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., de Souza BO; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Sá LGDAV; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Christus University Center (UNICHRISTUS), Fortaleza, CE, Brazil., de Andrade Neto JB; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Christus University Center (UNICHRISTUS), Fortaleza, CE, Brazil., Cavalcanti BC; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Magalhães IL; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., de Moraes MO; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Júnior HVN; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., da Silva CR; School of Pharmacy, Laboratory of Bioprospection in Antimicrobial Molecules (LABIMAN), Federal University of Ceará, Fortaleza, CE, Brazil.; Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.

المصدر: Journal of medical microbiology [J Med Microbiol] 2024 Jul; Vol. 73 (7).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Microbiology Society Country of Publication: England NLM ID: 0224131 Publication Model: Print Cited Medium: Internet ISSN: 1473-5644 (Electronic) Linking ISSN: 00222615 NLM ISO Abbreviation: J Med Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Antifungal Agents*/pharmacology , Microbial Sensitivity Tests* , Candida*/drug effects , Candida*/growth & development , Propafenone*/pharmacology, Humans ; Itraconazole/pharmacology ; Drug Synergism ; Drug Resistance, Fungal/drug effects ; Candidiasis/microbiology ; Candidiasis/drug therapy ; Drug Repositioning

المؤلفون: Waldauf P; Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague 10, Czechia., Porizka M; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Horejsek J; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Otahal M; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Svobodova E; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Jurisinova I; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Maly M; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Brozek T; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Rulisek J; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Trachta P; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU., Tencer T; Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague 10, Czechia., Krajcova A; Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague 10, Czechia., Duska F; Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague 10, Czechia., Balik M; Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU.

المصدر: European heart journal. Acute cardiovascular care [Eur Heart J Acute Cardiovasc Care] 2024 May 28; Vol. 13 (5), pp. 414-422.

نوع المنشور: Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101591369 Publication Model: Print Cited Medium: Internet ISSN: 2048-8734 (Electronic) Linking ISSN: 20488726 NLM ISO Abbreviation: Eur Heart J Acute Cardiovasc Care Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone*/therapeutic use , Propafenone*/administration & dosage , Amiodarone*/therapeutic use , Amiodarone*/administration & dosage , Shock, Septic*/drug therapy , Shock, Septic*/physiopathology , Anti-Arrhythmia Agents*/therapeutic use , Anti-Arrhythmia Agents*/administration & dosage , Heart Atria*/physiopathology , Heart Atria*/diagnostic imaging , Heart Atria*/drug effects , Tachycardia, Supraventricular*/drug therapy , Tachycardia, Supraventricular*/physiopathology, Humans ; Male ; Female ; Aged ; Treatment Outcome ; Middle Aged ; Stroke Volume/physiology ; Stroke Volume/drug effects

المؤلفون: Nižnanská Ž; Institute of Forensic Medicine, Faculty of Medicine, Comenius University Bratislava, Sasinková 4, 81108 Bratislava, Slovakia.; Department of Forensic Medicine and Toxicology, Health Care Surveillance Authority, Antolská 11, 85107 Bratislava, Slovakia.; Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University Bratislava, Mlynská Dolina, Ilkovičova 6, 84215 Bratislava, Slovakia., Hengerics Szabó A; Department of Chemistry, Faculty of Education, J. Selye University, Bratislavská cesta 3322, 94501 Komárno, Slovakia., Masár M; Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University Bratislava, Mlynská Dolina, Ilkovičova 6, 84215 Bratislava, Slovakia., Szucs R; Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University Bratislava, Mlynská Dolina, Ilkovičova 6, 84215 Bratislava, Slovakia., Šikuta J; Department of Forensic Medicine and Toxicology, Health Care Surveillance Authority, Antolská 11, 85107 Bratislava, Slovakia., Nižnanský Ľ; Institute of Forensic Medicine, Faculty of Medicine, Comenius University Bratislava, Sasinková 4, 81108 Bratislava, Slovakia.; Department of Forensic Medicine and Toxicology, Health Care Surveillance Authority, Antolská 11, 85107 Bratislava, Slovakia.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 May 10; Vol. 25 (10). Date of Electronic Publication: 2024 May 10.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone*/poisoning, Humans ; Tissue Distribution ; Male ; Gas Chromatography-Mass Spectrometry ; Tandem Mass Spectrometry ; Anti-Arrhythmia Agents/poisoning ; Fatal Outcome ; Adult

المؤلفون: Karwowski J; Department of Heart Diseases, Medical Centre of Postgraduate Education, Warsaw, Poland. karwowski.jarek@gmail.com, Wrzosek K; Department of Heart Diseases, Medical Centre of Postgraduate Education, Warsaw, Poland, Mączyńska-Mazuruk R; Department of Heart Diseases, Medical Centre of Postgraduate Education, Warsaw, Poland, Szmarowska K; Second Department of Cardiology, Masovian Brodnowski Hospital, Warsaw, Poland, Rekosz J; Second Department of Cardiology, Masovian Brodnowski Hospital, Warsaw, Poland, Wiktorska A; Second Department of Cardiology, Masovian Brodnowski Hospital, Warsaw, Poland, Mierzejewska B; Second Department of Cardiology, Masovian Brodnowski Hospital, Warsaw, Poland, Solecki M; Second Department of Cardiology, Masovian Brodnowski Hospital, Warsaw, Poland, Dłużniewski M; Department of Heart Diseases, Medical Centre of Postgraduate Education, Warsaw, Poland

المصدر: Polish archives of internal medicine [Pol Arch Intern Med] 2024 Apr 26; Vol. 134 (4). Date of Electronic Publication: 2024 Jan 02.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Medycyna Praktyczna Country of Publication: Poland NLM ID: 101700960 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1897-9483 (Electronic) Linking ISSN: 00323772 NLM ISO Abbreviation: Pol Arch Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone*/therapeutic use , Atrial Fibrillation*/drug therapy , Antazoline*/therapeutic use , Anti-Arrhythmia Agents*/therapeutic use , Anti-Arrhythmia Agents*/adverse effects, Humans ; Double-Blind Method ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome

المؤلفون: Yan S; Department of Cardiology, Tianjin First Central Hospital, Tianjin, China., Xin T; Department of Cardiology, Tianjin First Central Hospital, Tianjin, China., Luo X; Department of Emergency, Tianjin First Central Hospital, Tianjin, China., Wang Y; Department of Emergency, Tianjin First Central Hospital, Tianjin, China., Chen B; Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.

المصدر: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc [Ann Noninvasive Electrocardiol] 2024 Mar; Vol. 29 (2), pp. e13111.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Wiley Periodicals, Inc Country of Publication: United States NLM ID: 9607443 Publication Model: Print Cited Medium: Internet ISSN: 1542-474X (Electronic) Linking ISSN: 1082720X NLM ISO Abbreviation: Ann Noninvasive Electrocardiol Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone* , Diazepam*/therapeutic use, Female ; Humans ; Adolescent ; Suicidal Ideation ; Electrocardiography ; Electrodes

المؤلفون: Springer J; Division of Preventive Medicine and Education, Medical Univer sity of Gdańsk, Poland. janusz.springer@gumed.edu.pl., Pejska M; Department of Internal Medicine, Provincial Specialist Hospital in Słupsk, Poland., Kozłowski D; Institute of Health Sciences, Pomeranian University in Słupsk, Poland.

المصدر: Cardiology journal [Cardiol J] 2024; Vol. 31 (3), pp. 499-501. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Letter; Comparative Study; Journal Article

بيانات الدورية: Publisher: Via Medica Country of Publication: Poland NLM ID: 101392712 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1898-018X (Electronic) Linking ISSN: 1898018X NLM ISO Abbreviation: Cardiol J Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Arrhythmia Agents*/therapeutic use , Emergency Service, Hospital* , Flecainide*/therapeutic use , Amiodarone*/therapeutic use , Heart Rate*/drug effects , Propafenone*/therapeutic use, Humans ; Male ; Treatment Outcome ; Female ; Antazoline/therapeutic use ; Aged ; Middle Aged ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/physiopathology

المؤلفون: Kojić D; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Radunović A; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Bukumirić Z; Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia., Rajsic S; Department of Anesthesia and Intensive Care Medicine, Medical University Innsbruck, Innsbruck, Austria., Sušić M; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Marić M; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Žugić V; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Jurčević R; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia., Tomović M; Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia.

المصدر: Clinical cardiology [Clin Cardiol] 2023 Oct; Vol. 46 (10), pp. 1220-1226. Date of Electronic Publication: 2023 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-8737 (Electronic) Linking ISSN: 01609289 NLM ISO Abbreviation: Clin Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone*/adverse effects , Ventricular Premature Complexes*/diagnosis , Ventricular Premature Complexes*/drug therapy, Humans ; Flecainide/adverse effects ; Sotalol/adverse effects ; Retrospective Studies ; Electrocardiography ; Anti-Arrhythmia Agents/adverse effects

المؤلفون: To SY; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.; School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan.; School of Public Health, National Defense Medical Center, Taipei 114, Taiwan., Lin HT; Department of Ophthalmology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.; National Defense Medical Center, Graduate Institute of Medical Sciences, Taipei 114, Taiwan., Liao CC; Department of Family Medicine, Taichung Armed Forces General Hospital, Taichung 411, Taiwan.; Department of Medical Education and Research, Taichung Armed Forces General Hospital, Taichung 411, Taiwan.; School of Medicine, National Defense Medical Center, Taipei 114, Taiwan., Pan KT; Bartlett School, Institute of Environmental Design and Engineering, UCL, London, WC1E 6BT, United Kingdom.; National Defense Medical Centre, Graduate Institute of Aerospace and Undersea Medicine, Taipei 114, Taiwan., Wen YL; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.; School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan., Kao S; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.; School of Public Health, National Defense Medical Center, Taipei 114, Taiwan., Kao LT; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.; School of Pharmacy, National Defense Medical Center, Taipei 114, Taiwan.; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei 114, Taiwan.

المصدر: Postgraduate medical journal [Postgrad Med J] 2024 Jul 18; Vol. 100 (1186), pp. 584-591.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print Cited Medium: Internet ISSN: 1469-0756 (Electronic) Linking ISSN: 00325473 NLM ISO Abbreviation: Postgrad Med J Subsets: MEDLINE

مواضيع طبية MeSH: Amiodarone*/adverse effects , Cataract*/chemically induced , Cataract*/epidemiology , Anti-Arrhythmia Agents*/adverse effects, Humans ; Male ; Female ; Taiwan/epidemiology ; Middle Aged ; Aged ; Incidence ; Adult ; Risk Factors ; Proportional Hazards Models ; Cohort Studies ; Propafenone/adverse effects

المؤلفون: Balik M; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia. Electronic address: martin.balik@vfn.cz., Waldauf P; Department of Anaesthesiology and Intensive Care, 3(rd) Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Czechia., Maly M; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Brozek T; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Rulisek J; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Porizka M; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Sachl R; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Otahal M; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Brestovansky P; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Svobodova E; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Flaksa M; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Stach Z; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Horejsek J; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Volny L; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Jurisinova I; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Novotny A; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Trachta P; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Kunstyr J; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Kopecky P; Department of Anaesthesiology and Intensive Care, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, Czechia., Tencer T; Department of Anaesthesiology and Intensive Care, 3(rd) Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Czechia., Pazout J; Department of Anaesthesiology and Intensive Care, 3(rd) Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Czechia., Krajcova A; Department of Anaesthesiology and Intensive Care, 3(rd) Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Czechia., Duska F; Department of Anaesthesiology and Intensive Care, 3(rd) Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Czechia.

المصدر: Journal of critical care [J Crit Care] 2024 Oct; Vol. 83, pp. 154832. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8610642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8615 (Electronic) Linking ISSN: 08839441 NLM ISO Abbreviation: J Crit Care Subsets: MEDLINE

مواضيع طبية MeSH: Shock, Septic*/therapy , Shock, Septic*/physiopathology , Shock, Septic*/complications , Electric Countershock* , Echocardiography*, Humans ; Male ; Female ; Aged ; Middle Aged ; Anti-Arrhythmia Agents/therapeutic use ; Recurrence ; Amiodarone/therapeutic use ; Amiodarone/administration & dosage ; Propafenone/therapeutic use ; Propafenone/administration & dosage ; Tachycardia, Supraventricular/therapy ; Tachycardia, Supraventricular/physiopathology ; Tachycardia, Supraventricular/diagnostic imaging ; Prospective Studies

المؤلفون: Chin CG; Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC.; Division of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, and Taipei Heart Institute, Taipei, Taiwan, ROC., Hsieh YC; Cardiovascular Center, Taichung Veterans General Hospital, and National Chung Hsing University College of Medicine, Taichung, Taiwan, ROC.; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC., Lin WS; Division of Cardiovascular Medicine, Department of Internal Medicine, Tri-Service General Hospital, and National Defense Medical Center, Taipei, Taiwan, ROC., Lin YJ; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Chiou CW; Division of Cardiovascular Medicine, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC., Lin TH; Division of Cardiovascular Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC., Huang CL; Division of Cardiovascular Medicine, Department of Internal Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC., Hung Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Tri-Service General Hospital, and National Defense Medical Center, Taipei, Taiwan, ROC., Lin YK; Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC.; Division of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, and Taipei Heart Institute, Taipei, Taiwan, ROC., Chang SL; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Yeh TC; Division of Cardiovascular Medicine, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC., Lee HC; Division of Cardiovascular Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC., Lai WT; Division of Cardiovascular Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC., Hsieh MH; Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, ROC.; Division of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, and Taipei Heart Institute, Taipei, Taiwan, ROC.

المصدر: Journal of the Chinese Medical Association : JCMA [J Chin Med Assoc] 2023 May 01; Vol. 86 (5), pp. 472-478. Date of Electronic Publication: 2023 Feb 17.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1728-7731 (Electronic) Linking ISSN: 17264901 NLM ISO Abbreviation: J Chin Med Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Propafenone*/therapeutic use , Atrial Fibrillation*, Humans ; Anti-Arrhythmia Agents/adverse effects ; Electrocardiography ; Taiwan ; Treatment Outcome